Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 11, 2025 • 11:11 AM ET

Date/Time Source News Release
05/22/2025 07:00 AM EDT Business Wire Delcath Systems Issues Full Year 2025 Guidance
05/15/2025 04:30 PM EDT Business Wire Delcath Systems to Participate at the Craig-Hallum 22nd Annual Investor Conference
05/09/2025 05:30 PM EDT Business Wire Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05/08/2025 07:30 AM EDT Business Wire Delcath Systems Reports First Quarter 2025 Results and Business Highlights
04/28/2025 08:30 AM EDT Business Wire Delcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO(TM) in Liver-Dominant Metastatic Breast Cancer
04/24/2025 04:01 PM EDT Business Wire Delcath Systems to Host First Quarter 2025 Earnings Call
04/09/2025 05:00 PM EDT Business Wire Delcath Systems Announces Publication of Comparative Analysis from Randomized Portion of FOCUS Study in Metastatic Uveal Melanoma
03/27/2025 04:45 PM EDT GlobeNewswire Beta Bionics Announces Board Appointment of Gerard Michel
03/24/2025 04:01 PM EDT Business Wire Delcath Systems to Participate at the Canaccord Genuity Horizons in Oncology Virtual Conference
03/14/2025 04:01 PM EDT Business Wire Delcath Systems, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Page